Ligand validation:7KH9

IM2: (5R)-5-[(1S,2R)-1-formyl-2-hydroxypropyl]-3-[(2-{[(E)-iminomethyl]amino}ethyl)sulfanyl]-4,5-dihydro-1H-pyrrole-2-carbox ylic acid

IM2 is a Ligand Of Interest in 7KH9 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7KH9_IM2_B_301	16%	60%	0.225	0.793	0.43	1.09	-	1	0	0	100%	0.775
7KH9_IM2_A_301	5%	57%	0.288	0.686	0.46	1.17	-	1	2	0	100%	0.77
6P97_IM2_A_301	20%	13%	0.215	0.816	1.3	2.66	1	2	2	0	100%	0.9375
5QB4_IM2_B_301	18%	31%	0.218	0.803	1.21	1.53	2	2	0	0	100%	0.87
4GOG_IM2_B_501	94%	41%	0.071	0.972	1.18	1.12	1	1	0	0	100%	0.7155
6IYW_IM2_E_501	82%	5%	0.095	0.949	3.27	1.97	6	2	1	0	100%	1
4BEN_IM2_A_500	80%	21%	0.112	0.96	1.37	1.91	4	1	0	0	100%	0.75
1JVJ_IM2_A_300	79%	13%	0.101	0.945	1.75	2.25	2	6	0	0	100%	1
4H8R_IM2_A_501	74%	20%	0.095	0.924	1.43	1.94	2	2	0	0	100%	0.5165

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.